Concepedia

Donald H. Jenkinson

DH

Statistics

Publications

15

Citations

634

H-Index

12

Active since

1978

Affiliations

University College London(Current)

Aristotle University of Thessaloniki

Universidad de Granada

Donald H. Jenkinson is an author at University College London specializing in pharmacology, medicine, and molecular pharmacology.

Publications per year

1978–2007

15

Publications

15

Synthesis, Molecular Modeling, and Pharmacological Testing of Bis-Quinolinium Cyclophanes: Potent, Non-Peptidic Blockers of the Apamin-Sensitive Ca<sup>2+</sup>-Activated K<sup>+</sup>Channel

Joaquín M. Campos Rosa, Dimitrios Galanakis, Alessandro Piergentili et al. · Journal of Medicinal Chemistry · 1999 · 94 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Bis-Quinolinium Cyclophanes: 6,10-Diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non-Peptidic Blocker of the Apamin-Sensitive Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel

Joaquín M. Campos Rosa, Dimitrios Galanakis, C. Robin Ganellin et al. · Journal of Medicinal Chemistry · 1998 · 79 citations

Medicine, Chemistry, Pharmacology +5

Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscle

Neil A. Castle, D.G. Haylett, Joanna M. Morgan et al. · European Journal of Pharmacology · 1993 · 67 citations

Medicine, Pharmacology, Physiology +12

SK3 is an important component of K<sup>+</sup> channels mediating the afterhyperpolarization in cultured rat SCG neurones

Ramine Hosseini, David C. Benton, Philip M. Dunn et al. · The Journal of Physiology · 2001 · 66 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

How we describe competitive antagonists: three questions of usage

Donald H. Jenkinson · Trends in Pharmacological Sciences · 1991 · 63 citations

Business, Strategy, Competitive Dynamics +4

1–5 of 15